A novel, cell culture-derived smallpox vaccine in vaccinia-naïve adults

Vaccine

Volumn 23, Issue 25, 2005, Pages 3301-3309

  Artenstein, Andrew W ^a   Johnson, Casey ^b   Marbury, Thomas C ^c   Morrison, Dennis ^d   Blum, Paul S ^e   Kemp, Tracy ^e   Nichols, Richard ^e   Balser, John P ^f   Currie, Michelle ^f   Monath, Thomas P ^e  

^a MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^b PRA HEALTH SCIENCES   (United States)

^c ORLANDO CLINICAL RESEARCH CENTER   (United States)

^d Bio Kinetic Clinical Applications   (United States)

^e Acambis   (United States)

^f Veristat Inc   (United States)

Author keywords

Myopericarditis; Smallpox vaccine; Vaccinia

Indexed keywords

NEUTRALIZING ANTIBODY; SMALLPOX VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CELL CULTURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DILUTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EDEMA; ERYTHEMA; FATIGUE; FEMALE; HEADACHE; HUMAN; INJECTION PAIN; INJECTION SITE REACTION; LYMPHADENOPATHY; MALAISE; MALE; MYALGIA; NAUSEA; NORMAL HUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RIGOR; SIDE EFFECT; SMALLPOX; UNITED STATES; VACCINATION; VACCINIA; VOMITING;

EID: 20244365201     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.079     Document Type: Article

References (20)

1. F. Fenner, D.A. Henderson, I. Arita, Z. Jezek, and I.D. Ladnyi Smallpox and its Eradication 1988 World Health Organization Geneva
2. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2001;50:1-25.
3. D.A. Henderson, T.V. Inglesby, J.G. Bartlett, M.S. Ascher, E. Eitzen, and P.B. Jahrling Smallpox as a biological weapon: medical and public health management JAMA 281 1999 2127 2137
4. S.E. Frey, F.K. Newman, J. Cruz, W.B. Shelton, J.M. Tennant, and T. Polach Dose-related effects of smallpox vaccine N Engl J Med 346 2002 1275 1280
5. S.E. Frey, R.B. Couch, C.O. Tackett, J.J. Treanor, M. Wolff, and F.K. Newman Clinical responses to undiluted and diluted smallpox vaccine N Engl J Med 346 2002 1265 1274
6. D.A. Henderson, L.L. Borio, and J.M. Lane Smallpox and vaccinia S.A. Plotkin W.A. Orenstein Vaccines 4th ed. 2004 Elsevier, Inc. Philadelphia 123 153
7. Acambis, Inc. Investigator's Brochure for ACAM2000 Smallpox Vaccine, Cambridge, MA; August 2002.
8. R. Weltzin, J. Liu, K.V. Pugachev, G.A. Myers, B. Coughlin, and P.S. Blum Clonal vaccinia virus grown in cell culture as a new smallpox vaccine Nat Med 9 2003 1125 1130
9. T.P. Monath, J.R. Caldwell, W. Mundt, J. Fusco, C.S. Johnson, and M. Buller ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) - a second-generation smallpox vaccine for biological defense Int J Infect Dis 8 Suppl. 2 2004 31 44
10. Centers for Disease Control and Prevention. Cardiac events following smallpox vaccination - United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:248-50.
11. E. Hammarlund, M.W. Lewis, S.G. Hansen, L.I. Strelow, J.A. Nelson, and G.J. Sexton Duration of antiviral immunity after smallpox vaccination Nat Med 9 2003 1131 1137
12. J.M. Lane, F.L. Ruben, J.M. Neff, and J.D. Millar Complications of smallpox vaccination, 1968 N Engl J Med 281 1969 1201 1208
13. V.A. Fulginiti, A. Papier, J.M. Lane, J.M. Neff, and D.A. Henderson Smallpox vaccination: a review, part II. Adverse events Clin Infect Dis 37 2003 251 271
14. M.K. Arness, R.E. Eckart, S.S. Love, J.E. Atwood, T.S. Wells, and R.J. Engler Myopericarditis following smallpox vaccination Am J Epidemiol 160 2004 642 651
15. J.D. Grabenstein, and W. Winkenwerder Jr US military smallpox vaccination program experience JAMA 289 2003 3278 3282
16. Centers for Disease Control and Prevention. Update: Adverse events following civilian smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:819-20.
17. Centers for Disease Control and Prevention. Update: Cardiac and other adverse events following civilian smallpox vaccination-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:639-42.
18. R.J. Engler, J. Kenner, and D.Y. Leung Smallpox vaccination: risk considerations for patients with atopic dermatitis J Allergy Clin Immunol 110 2002 357 365
19. T.R. Talbot, H.K. Bredenberg, M. Smith, B.J. LaFleur, A. Boyd, and K.M. Edwards Focal and generalized folliculitis following smallpox vaccination among vaccinia-naïve recipients JAMA 289 2003 3290 3294
20. A.R. Kemper, M.M. Davis, and G.L. Freed Expected adverse events in a mass smallpox vaccination campaign Eff Clin Pract 5 2002 84 89